Work

Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.2095

Authors: Thomas Joseph Kaley, Elena Pentsova, Antonio Marcilio Padula Omuro, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic, Lisa Marie DeAngelis, Mario E. Lacouture, Eric C. Holland, Andrew B. Lassman

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2779458276

Cites:

Cited by: 5

Related to: 10